Compared with white patients, black patients with screen-detected cancers had a lower calculated lung cancer risk, despite having a significantly higher mean 6-year lung cancer risk.
Patients with COVID-19 pneumonia may present with 2 distinct phenotypes, each warranting distinct treatments.
Fibrosis indicators, including lymphocyte count and C-reactive protein, may be used as early warning signs of poor prognosis in patients with COVID-19.
Right atrial conduit phase emptying may predict the risk for adverse clinical events in pediatric patients with pulmonary arterial hypertension.
Routine testing for non-SARS-CoV-2 pathogens is unlikely to provide clinical benefit unless a positive result would alter the disease management.
Chronic obstructive pulmonary disease is associated with a greater than 5-fold increased risk for severe coronavirus disease 2019 infection.
A joint statement issued by the Society of Critical Care Medicine and several other medical societies has advised against the use of 1 ventilator for multiple patients.
In patients who were hospitalized with severe coronavirus disease, treatment with lopinavir-ritonavir did not provide a substantial benefit beyond standard care.
The leadership of American Thoracic Society recently released a statement, as well as 2 fact sheets, in response to the COVID-19 outbreak.
The annual meeting of the American Academy of Allergy, Asthma & Immunology has been canceled, but the research will still be shared and promoted.
